“Looking for the very highest quality products and the consistency of a high-tech pharmaceuticals operation? Vida expects to file its licensing application before the end of April, a schedule that should allow it to have the necessary license in hand by the third quarter of this year. In the meantime, the company is raising $1.5 million at $.25 per share. That represents a market value of only $6 million for a company that now owns a 315,000-square-foot production plant with a replacement value estimated at $30 million. Personally, I think this will turn out to be an extraordinary investment. In less than a year’s time, this $.25 financing round is going to look extremely cheap.”
Related posts:
The Totalitarian One-way Mirror
Why is California Jailing Landscapers? Don't Cops Have Better Things to Do?!
Martin Armstrong: Kiss Your Pension Fund Goodbye
What Don't We Understand at This Point About Economics and Unemployment?
Reality Check: Senate Moving Forward On Internet Tax Mandate
Meet the traveling Bitcoin ATM
Debate On Oklahoma Medical Marijuana Bill Continues
How Snowden Did an End Run Around the NSA and the Obama Administration
Yemeni Engineer Begs Obama to Stop Murdering His Family with Drones
Bitcoin-friendly Internet Credit Union suddenly dumps accounts: 'regulatory issues'
Dubai Will Issue First Ever State Cryptocurrency
Eric Holder: Some Banks Are So Large That It Is Difficult For Us To Prosecute Them
It’s (Almost) Official: Tax Debt = No Passport
China's Gold Fever Rises, Showing No Signs Of Abating
Congress Asks Bernanke For Full Risk Analysis On Fed's Soaring Balance Sheet